Abstract
Mitral regurgitation (MR) is a common problem and results in high health care consumption and increased morbidity and mortality. Delivering energy at subablative temperatures appears to produce contraction of the mitral valve annulus (MA) and may reduce mitral regurgitation by improving leaflet coaptation. It was hypothesized that therapeutic ultrasound (TU) from the ReCor (ReCor, Ronkonkoma, NY, USA; Investigational device, not for use in human application) device could result in such MA size reduction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
